SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-012027
Filing Date
2018-05-09
Accepted
2018-05-08 20:01:30
Documents
74
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q prtk-10q_20180331.htm 10-Q 1368508
2 EX-31.1 prtk-ex311_10.htm EX-31.1 18164
3 EX-31.2 prtk-ex312_13.htm EX-31.2 18328
4 EX-32.1 prtk-ex321_6.htm EX-32.1 6520
5 EX-32.2 prtk-ex322_8.htm EX-32.2 6420
  Complete submission text file 0001564590-18-012027.txt   6689344

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT prtk-20180331.xml EX-101.INS 1443661
7 XBRL TAXONOMY EXTENSION SCHEMA prtk-20180331.xsd EX-101.SCH 66382
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE prtk-20180331_cal.xml EX-101.CAL 49138
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE prtk-20180331_def.xml EX-101.DEF 217521
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE prtk-20180331_lab.xml EX-101.LAB 474438
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE prtk-20180331_pre.xml EX-101.PRE 358526
Mailing Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116
Business Address 75 PARK PLAZA 4TH FLOOR BOSTON MA 02116 (617) 807-6600
Paratek Pharmaceuticals, Inc. (Filer) CIK: 0001178711 (see all company filings)

IRS No.: 330960223 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36066 | Film No.: 18816356
SIC: 2834 Pharmaceutical Preparations